Cargando…
Inflammation as a Risk Factor in Cardiotoxicity: An Important Consideration for Screening During Drug Development
Numerous commonly prescribed drugs, including antiarrhythmics, antihistamines, and antibiotics, carry a proarrhythmic risk and may induce dangerous arrhythmias, including the potentially fatal Torsades de Pointes. For this reason, cardiotoxicity testing has become essential in drug development and a...
Autores principales: | Campana, Chiara, Dariolli, Rafael, Boutjdir, Mohamed, Sobie, Eric A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8091045/ https://www.ncbi.nlm.nih.gov/pubmed/33953668 http://dx.doi.org/10.3389/fphar.2021.598549 |
Ejemplares similares
-
Predicting individual-specific cardiotoxicity responses induced by tyrosine kinase inhibitors
por: Shim, Jaehee V., et al.
Publicado: (2023) -
Investigational treatments for COVID-19 may increase ventricular arrhythmia risk through drug interactions
por: Varshneya, Meera, et al.
Publicado: (2020) -
Investigational Treatments for COVID‐19 may Increase Ventricular Arrhythmia Risk Through Drug Interactions
por: Varshneya, Meera, et al.
Publicado: (2021) -
Investigational Treatments for COVID-19 May Increase Ventricular Arrhythmia Risk through Drug Interactions
por: Varshneya, Meera, et al.
Publicado: (2021) -
In vitro and In silico Models to Study SARS-CoV-2 Infection: Integrating Experimental and Computational Tools to Mimic “COVID-19 Cardiomyocyte”
por: Dariolli, Rafael, et al.
Publicado: (2021)